Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogenic Bone Marrow Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03696537
What this trial is testing

IMRT-TMI With Fludarabine as Myeloablative Conditioning for Allogeneic HSCT

Who this might be right for
Acute Myeloid LeukemiaChronic Myeloid LeukemiaAcute Lymphocytic Leukemia+1 more
Naoyuki G. Saito, M.D., Ph.D. 6
Testing effectiveness (Phase 2)Temporarily pausedNCT05617625
What this trial is testing

CD34+ Enriched Transplants to Treat Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic SyndromesGraft Vs Host DiseaseGraft-versus-host-disease
Guenther Koehne 50
Early research (Phase 1)UnknownNCT04429191
What this trial is testing

JSP191 Antibody Conditioning Regimen in MDS/AML Subjects Undergoing Allogenic Hematopoietic Stem Cell Transplantation

Who this might be right for
MYELODYSPLASTIC SYNDROME; MDSACUTE MYELOID LEUKEMIA; AML
Jasper Therapeutics, Inc. 40
Early research (Phase 1)Study completedNCT03885947
What this trial is testing

VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies

Who this might be right for
Hematological MalignancyAcute Leukemia in RemissionAcute Lymphoblastic Leukemia in Remission+3 more
Alla Keyzner 7
Not applicableStudy completedNCT00954720
What this trial is testing

Observational Study of Iron Overload in Stem Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaMyelodysplastic Syndrome
Dana-Farber Cancer Institute 45
Testing effectiveness (Phase 2)Looking for participantsNCT07532824
What this trial is testing

Proton-Based Total Marrow Irradiation for Allogeneic Transplantation in High-Risk AML/MDS

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)/AMLProton Therapy+2 more
Institute of Hematology and Blood Transfusion, Czech Republic 16
Testing effectiveness (Phase 2)Looking for participantsNCT07301866
What this trial is testing

A Study Testing an Improved Dose of UM171 to Help Make Cord Blood Transplants More Effective and Safe.

Who this might be right for
Acute Leukemia, High RiskMyelodysplastic Syndromes, High RiskHematologic Malignancy Requiring an Allogeneic Hematopoietic Stem Cell Transplant Lacking a Donor
Ciusss de L'Est de l'Île de Montréal 7
Testing effectiveness (Phase 2)Study completedNCT01562002
What this trial is testing

Safety Study of Stem Cell Transplant to Treat Limbus Insufficiency Syndrome

Who this might be right for
Limbus Corneae Insufficiency Syndrome
Instituto Universitario de Oftalmobiología Aplicada (Institute of Applied Ophthalmobiology) - IOBA 27
Early research (Phase 1)Ended earlyNCT01663766
What this trial is testing

Phase I Study of Milatuzumab for Graft Versus Host Disease

Who this might be right for
GVHD (Acute or Chronic)Acute Myeloid or Lymphoblastic Leukemia (AML or ALL)Myelodysplastic Syndrome+4 more
Gilead Sciences 12
Early research (Phase 1)WithdrawnNCT02677246
What this trial is testing

Denosumab for Prevention of Bone Complications After Bone Marrow Transplantation in Children

Who this might be right for
Disorder Related to Bone Marrow Transplantation
St. Justine's Hospital
Testing effectiveness (Phase 2)Study completedNCT00185796
What this trial is testing

TLI & ATG for Non-Myeloablative Allogeneic Transplantation for MDS and MPD

Who this might be right for
Myeloproliferative DisordersBlood CancerMyelodysplastic Syndromes
Stanford University 77
Testing effectiveness (Phase 2)Study completedNCT00064311
What this trial is testing

Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
National Institutes of Health Clinical Center (CC)
Testing effectiveness (Phase 2)Study completedNCT00491634
What this trial is testing

Treosulfan-based Conditioning for Transplantation in AML/MDS

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndrome
Dr. Avichai Shimoni MD 24
Testing effectiveness (Phase 2)Looking for participantsNCT06315309
What this trial is testing

Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

Who this might be right for
GVHD,AcuteAcute LeukemiaMyelodysplastic Syndromes+1 more
University of Alabama at Birmingham 29
Early research (Phase 1)Active Not RecruitingNCT03613532
What this trial is testing

Venetoclax Added to Fludarabine + Busulfan Prior to Transplant and to Maintenance Therapy for AML, MDS, and MDS/MPN

Who this might be right for
Acute Myeloid Leukemia (AML)Myelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML)+2 more
Jacqueline Garcia, MD 102
Large-scale testing (Phase 3)UnknownNCT00998270
What this trial is testing

Autologous Bone Marrow Transplantation (BMT) Compared With Allogeneic BMT in Multiple Myeloma

Who this might be right for
Multiple Myeloma
Tehran University of Medical Sciences 185
Testing effectiveness (Phase 2)Ended earlyNCT01596699
What this trial is testing

Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation

Who this might be right for
Myeloid MalignancyBone Marrow Failure SyndromeTransfusion-dependent Red Blood Cell (RBC) Defect+3 more
University of California, San Francisco 16
Testing effectiveness (Phase 2)Study completedNCT01379209
What this trial is testing

Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

Who this might be right for
Graft Versus Host Disease
Regimmune Corporation 68
Early research (Phase 1)Study completedNCT01822509
What this trial is testing

Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Transplant

Who this might be right for
Allogeneic Hematopoietic Stem Cell Transplant RecipientMyeloproliferative NeoplasmRecurrent Acute Lymphoblastic Leukemia+8 more
National Cancer Institute (NCI) 71
Testing effectiveness (Phase 2)Study completedNCT00673114
What this trial is testing

Unrelated Cord Blood Transplant Plus a Haplo-Identical (Half-Matched), T-Cell Depleted Stem Transplant From a Related Donor for Subjects With High Risk Malignancies

Who this might be right for
Hematologic MalignancyMyelodysplastic Syndrome (MDS)Aplastic Anemia
Joanne Kurtzberg, MD 3
Next Page